Prevalence and numbers of Salmonella and Campylobacter spp. on raw, whole chickens in relation to sampling methods

Autor: R.A. Bailey, Linda R. Ward, JA Frost, Dra Wareing, Frieda Jørgensen, S. S. Williams, F. J. Bolton, Tom J. Humphrey, Peter A. Henderson

Publikováno v: International Journal of Food Microbiology. 76:151-164

Salmonella and Campylobacter continue to be major foodborne pathogens and raw poultry is considered to be an important source of these bacteria. In this study, the prevalence and numbers of Salmonella and Campylobacter spp. in relation to isolation/s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45c75ba94be463fa366e821d94a342fe
https://doi.org/10.1016/s0168-1605(02)00027-2

The agricultural decision process in a small tank cascade system in Sri Lanka: diagnosing options for adaptive governance.

Autor: Kekulandala, Bhathiya¹ Bhathiya.Kekulandala@alumni.uts.edu.au, Jacobs, Brent¹, Cunningham, Rebecca¹

Publikováno v: Discover Agriculture. 7/16/2024, Vol. 2 Issue 1, p1-17. 17p.

Macitentan in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (CTD-PAH): Real-World Evidence from the Combined OPUS/OrPHeUS Dataset.

Autor: Channick, Richard¹ (AUTHOR) rchannick@mednet.ucla.edu, Chin, Kelly M.² (AUTHOR), McLaughlin, Vallerie V.³ (AUTHOR), Lammi, Matthew R.⁴ (AUTHOR), Zamanian, Roham T.⁵ (AUTHOR), Turricchia, Stefano⁶ (AUTHOR), Ong, Rose⁷ (AUTHOR), Mitchell, Lada⁸ (AUTHOR), Kim, Nick H.⁹ (AUTHOR)

Publikováno v: Cardiology & Therapy. Jun2024, Vol. 13 Issue 2, p315-339. 25p.

Initial combination therapy with macitentan and tadalafil in patients with pulmonary arterial hypertension, with and without cardiac comorbidities.

Autor: McLaughlin VV; University of Michigan, Ann Arbor, MI, USA., Sitbon O; Université Paris-Saclay, Hôpital Bicêtre, Le Kremlin Bicêtre, France., Chin KM; UT Southwestern Medical Center, Dallas, TX, USA., Galiè N; Cardiology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Dipartimento DIMEC, Università di Bologna, Bologna, Italy., Hoeper MM; Hannover Medical School and German Centre for Lung Research, Hannover, Germany., Kiely DG; Sheffield Pulmonary Vascular Disease Unit, NIHR Biomedical Research Centre Sheffield and University of Sheffield, Sheffield, UK., MacDonald G; Actelion Pharmaceuticals Ltd, a Johnson & Johnson Company, Global Medical Affairs, Allschwil, Switzerland., Martin N; Actelion Pharmaceuticals Ltd, a Johnson & Johnson Company, Statistical Decision Science, Allschwil, Switzerland., Mathai SC; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Peacock A; Scottish Pulmonary Vascular Unit, Glasgow, UK., Tawakol A; Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Torbicki A; Department of Pulmonary Circulation, Thromboembolic Diseases and Cardiology, Centre of Postgraduate Medical Education, ECZ-Otwock, ERN-LUNG Member, Otwock, Poland., Noordegraaf AV; Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Rosenkranz S; Department of Cardiology, Heart Center at the University Hospital Cologne, and Cologne Cardiovascular Research Center (CCRC), University of Cologne, Cologne, Germany.

Publikováno v: European journal of heart failure [Eur J Heart Fail] 2024 Jul 05. Date of Electronic Publication: 2024 Jul 05.

Should obstetric cholestasis remain a diagnosis of exclusion?

Autor: JA Frost, J Trinder

Publikováno v: Archives of Disease in Childhood - Fetal and Neonatal Edition. 97:A49.1-A49

Objective To determine whether exclusion of other causes of liver dysfunction is necessary in the diagnosis of obstetric cholestasis(OC), previous studies have not addressed this question. Methods Retrospective analysis of investigations undertaken t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5016cd30a879b07eaaac79f352f85bf0
https://doi.org/10.1136/fetalneonatal-2012-301809.155